J Freiman

495 total citations
6 papers, 360 citations indexed

About

J Freiman is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, J Freiman has authored 6 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 2 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Surgery. Recurrent topics in J Freiman's work include Chronic Lymphocytic Leukemia Research (2 papers), Neuroendocrine Tumor Research Advances (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). J Freiman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Neuroendocrine Tumor Research Advances (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). J Freiman collaborates with scholars based in United States. J Freiman's co-authors include Sandra L. Kweder, R B Weiss, Louis F. Diehl, John C. Byrd, Ross Mabon, Nicole C. Goodwin, Kenny Frazier, David B. Rawlins, Phil Brown and Anne Turnage and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Clinical Pharmacology & Therapeutics.

In The Last Decade

J Freiman

6 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Freiman United States	5	180	123	99	95	59	6	360
Tuli Ahmed United States	9	165 0.9×	336 2.7×	70 0.7×	91 1.0×	15 0.3×	12	599
Agustin Melian United States	6	196 1.1×	50 0.4×	25 0.3×	63 0.7×	67 1.1×	10	495
Tomoko Usui Japan	14	57 0.3×	51 0.4×	17 0.2×	79 0.8×	61 1.0×	27	417
Kavita Shalia India	10	81 0.5×	74 0.6×	22 0.2×	57 0.6×	29 0.5×	32	334
Naomi Yoshioka Japan	7	78 0.4×	52 0.4×	15 0.2×	75 0.8×	12 0.2×	7	439
Olivera Marsenić United States	10	126 0.7×	119 1.0×	47 0.5×	88 0.9×	48 0.8×	32	396
T Kitajima Japan	7	158 0.9×	14 0.1×	60 0.6×	76 0.8×	25 0.4×	13	434
Selma Andréa Cavalli Brazil	9	89 0.5×	115 0.9×	21 0.2×	67 0.7×	23 0.4×	14	341
J Truffert France	10	112 0.6×	159 1.3×	10 0.1×	56 0.6×	74 1.3×	47	403
G Giudici Italy	11	90 0.5×	150 1.2×	14 0.1×	72 0.8×	57 1.0×	21	357

Countries citing papers authored by J Freiman

Since Specialization

Citations

This map shows the geographic impact of J Freiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Freiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Freiman more than expected).

Fields of papers citing papers by J Freiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Freiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Freiman. The network helps show where J Freiman may publish in the future.

Co-authorship network of co-authors of J Freiman

This figure shows the co-authorship network connecting the top 25 collaborators of J Freiman. A scholar is included among the top collaborators of J Freiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Freiman. J Freiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zambrowicz, Brian, J Freiman, Phil Brown, et al.. (2012). LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Clinical Pharmacology & Therapeutics. 92(2). 158–169. 202 indexed citations

2.

O’Dorisio, Thomas M., Alexandria T. Phan, Robert M. Langdon, et al.. (2011). A phase II, multicenter, randomized, double-blind, placebo-controlled, ascending, multidose, U.S. study of oral LX1606 (aka LX1032) in patients with refractory symptomatic carcinoid syndrome.. Journal of Clinical Oncology. 29(15_suppl). TPS168–TPS168. 2 indexed citations

3.

Weiss, R B, J Freiman, Sandra L. Kweder, Louis F. Diehl, & John C. Byrd. (1998). Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia.. Journal of Clinical Oncology. 16(5). 1885–1889. 84 indexed citations

4.

Andrews, Elizabeth, Jerry Avorn, Runsheng Chen, et al.. (1996). Guidelines for Good Epidemiology Practices for Drug, Device, and Vaccine Research in the United States. Pharmacoepidemiology and Drug Safety. 5(5). 333–338. 37 indexed citations

5.

Byrd, John C., Andrew Hertler, R B Weiss, et al.. (1995). Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Annals of Oncology. 6(3). 300–301. 31 indexed citations

6.

Freiman, J & N. Buchanan. (1978). Drug compliance and therapeutic considerations in 75 black epileptic children.. PubMed. 24(7). 136–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact